Clinical Trial

Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments. R61 PHASE

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical research study is to learn more about whether individual differences in brain responses to emotional triggers impact rTMS (repetitive transcranial magnetic stimulation) responses in people who smoke.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-05-22; most recent amendment 2026-07-20.
Trial Details
NCT Number NCT06991062
Lead Sponsor M.D. Anderson Cancer Center
Conditions Smoking
Enrollment 100 participants
Start Date 2025-02-19
Primary Completion 2026-12-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-21